Cargando…
Does fluoxetine reduce apathetic and depressive symptoms after stroke? An analysis of the Efficacy oF Fluoxetine—a randomized Controlled Trial in Stroke trial data set
OBJECTIVE: Apathy is a common and disabling symptom after stroke with no proven treatments. Selective serotonin reuptake inhibitors are widely used to treat depressive symptoms post-stroke but whether they reduce apathetic symptoms is unknown. We determined the effect of fluoxetine on post-stroke ap...
Autores principales: | Tay, Jonathan, Mårtensson, Björn, Markus, Hugh S, Lundström, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940155/ https://www.ncbi.nlm.nih.gov/pubmed/36050815 http://dx.doi.org/10.1177/17474930221124760 |
Ejemplares similares
-
Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden
por: Lundström, Erik, et al.
Publicado: (2020) -
Correction to: Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden
por: Lundström, Erik, et al.
Publicado: (2020) -
The functions of fluoxetine and identification of fluoxetine-mediated circular RNAs and messenger RNAs in cerebral ischemic stroke
por: He, Yitao, et al.
Publicado: (2021) -
The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials
por: Mead, Gillian, et al.
Publicado: (2015) -
The effects of Xingnao Jieyu capsules on post-stroke depression are similar to those of fluoxetine
por: Yan, Yongmei, et al.
Publicado: (2013)